Dual-color interphase fluorescence in situ hybridization (FISH) with ETV6 and AML1 probes was used for the first time on a series of 159 adult patients with acute lymphoblastic leukemia (ALL), for detection of the t(12;21)(p13;q22) translocation. Seven patients (4.4%) were found, with 50-100% of positive cells, of whom one of two tested, proved negative for the fusion product by RT-PCR. Two of them, aged 43 and 50 years, are the oldest patients so far confirmed to have the translocation. Three who relapsed at 10, 11 and 24 months, suggest that adults may not enjoy the good short-term prognosis reported for t(12;21)-positive children. Thirty-one-negative cases had signal numbers differing from the two expected for each gene. In 15 cases these results were consistent with the karyotype. In nine cases with uninformative cytogenetics, the numbers were consistent with those for centromeres and indicated a hidden aneuploidy. Loss of ETV6 genes in two cases and AML1 amplification in three others were not suspected from the cytogenetics. In conclusion, FISH proved to be reliable in defining ETV6/AML1 positivity in this group of patients as well as providing valuable insights into negative cases. Leukemia (2002) 16, 669-674.
Introduction
Abnormalities of the short arm of chromosome 12 (12p) are a frequent finding in hematological malignancies. Visible cytogenetic abnormalities of 12p were reported in 10% of children with acute lymphoblastic leukemia (ALL), 1 while loss of heterozygosity studies revealed deletions in 27% of cases. 2 When Romana et al 3 investigated eight cases of ALL with abnormalities of 12p using fluorescence in situ hybridization (FISH), a cryptic translocation involving the short arm of chromosome 12 and the long arm of chromosome 21, t(12;21)(p13;q22), was found in three of them. This translocation was subsequently demonstrated to involve the ETV6 (TEL) gene at 12p13 and the AML1 gene at 21q22.
Since the t(12;21) translocation is cytogenetically invisible, diagnosis is based on the identification of appropriate mRNA transcripts detected by the reverse transcriptase polymerase chain reaction (RT-PCR), or by the application of FISH using whole chromosome paints (wcp) or specific probes. 3, 5, 6 Numerous PCR-based studies have shown the abnormality to be the most common translocation in childhood ALL, occurring in 25% of B-lineage cases. [7] [8] [9] There is a much lower incidence (1-3%) in adults, with all reported cases except for one, 10 being less than 28 years of age. 6, [11] [12] [13] [14] The initial reports on the outlook for children harboring this translocation were based on retrospective studies on selected patients, which showed an event-free survival of up to 100% at 5 years, and a median event-free survival in excess of 8 years. 7, 8 This optimistic outlook was tempered by the more recent findings of comparable frequencies of the abnormality at relapse and presentation. 15, 16 There are, however, indications from prospective studies that the translocation may be particularly associated with late relapse. 15 The low incidence of t(12;21) in adults precludes accurate evaluation of prognosis.
Of interest, is the finding that all positive cases of both children and adults tested by RT-PCR, showed the ETV6/AML1 transcript, but only a proportion showed the reciprocal one. 6, 7 This suggests that ETV6/AML1 is the important product in leukemogenesis. 17, 18 Deletions of the homologous ETV6 allele have been reported in some cases with the t(12;21) translocation. They either occurred from all or from a proportion of the positive nuclei and were sometimes intragenic. 19, 20 It has been proposed that the extent of deletion of the second ETV6 allele and the presence or absence of other chromosomal abnormalities may identify subgroups of ETV6/AML1-positive patients with different outcomes. 20, 21 Interphase FISH allows the rapid assessment of a large number of cells in samples without metaphases, although the probes can be seen equally well on cells in division. The technique is being increasingly used in screening for prognostically significant abnormalities such as the BCR/ABL fusion of Philadelphia chromosome-positive ALL. 22 Dual-color interphase FISH to detect t(12;21) has similar advantages. Unlike RT-PCR with specific primers, the probes will also detect the abnormality when it arises from alternative breakpoints within the ETV6 and AML1 loci, as well as other abnormalities involving these genes. This study evaluates the role of interphase FISH in detecting the t(12;21) translocation in adult acute lymphoblastic leukemia.
Materials and methods

Patients and controls
Diagnostic bone marrow (148 samples) and peripheral blood (11 samples) were available from 159 adults with ALL presenting between February 1993 and April 2000. The patients included 151 who were entered into the current UK Medical Research Council adult ALL treatment trial (UKALLXII) and eight treated independently.
Nine bone marrow samples were selected as controls from adult patients with normal karyotypes and non-malignant hematological disease. They included six cases with immune thrombocytopenia, two with iron deficiency anemia and one with immune neutropenia.
Probes for FISH
Commercial probes for ETV6 and AML1 in a dual-color kit were used (LSI TEL/AML1 ES; Vysis, Downer's Grove, IL, USA). The probe for ETV6 extends from between exons 3 and 5 towards the short arm telomere of chromosome 12, covering approximately 350 kb, while the probe for AML1 extends over 500 kb spanning the entire gene and sequences telomeric to it. The probes are directly labeled with Spectrum Orange (AML1) and Spectrum Green (ETV6), and produce a yellow signal for the ETV6/AML1 fusion on the derived chromosome 21, a green signal for the ETV6 gene on the other homologue of chromosome 12, a red signal for AML1 on the normal chromosome 21, and a smaller red signal for the reciprocal product of the t(12;21) translocation on the derived chromosome 12. Normal interphase nuclei show two red and two green signals.
Whole chromosome paints (wcps) for chromosome 12 (digoxigenin labeled) and chromosome 21 (biotin labeled) (Cambio STAR*FISH Human Whole Chromosome-specific Probes) were used to confirm the t(12;21) translocation on metaphases.
The Chromoprobe Multiprobe-I system (Cytocell, Banbury, UK) (Multiprobe-I) is a device containing 24 directly labeled centromeric probes on a single coverslip and a customized slide with wells, into each of which fixed cells are dropped, allowing the enumeration of the centromeres of all 24 chromosomes in one test.
Cytogenetics
Diagnostic samples were processed by established short-term culture methods and the resulting fixed cell suspensions used for conventional chromosomal analysis and for FISH. All cases were initially investigated in the UK regional cytogenetic centers. The G-banded slides and karyotypes were then reviewed by the Leukaemia Research Fund/UK Cancer Cytogenetics Group (LRF/UKCCG) Karyotype Database in ALL. Karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN). 23 
Interphase FISH
All probes were hybridized according to manufacturers' instructions. Cells were analyzed using a Zeiss Axiophot epifluorescence microscope (Zeiss, Oberkochem, Germany) equipped with a 100 W mercury lamp. Images were captured using a cooled coupled device (CCD) camera (Photometrics, Tucson, AZ, USA) and analyzed using MacProbe software (Applied Imaging International, Newcastle, UK). The same investigator carried out all FISH analyses.
ETV6/AML1
A minimum of 100 nuclei and where possible 200 nuclei were scored for each sample. The number and the co-localization of the AML1 and ETV6 signals were determined for each nucleus. A co-localization of the red and green fluorescence was accepted if a yellow fusion signal produced by overlapping red and green signals was observed. The proportion of cells with co-localized signals was calculated as a percentage of the total number of nuclei analyzed for each patient. 
Multiprobe-I
Fixed cells were dropped on to the customized slide and cohybridized with the probe-bearing coverslip. One hundred nuclei were scored for each centromeric probe.
Metaphase FISH
Slides previously hybridized with dual-color probes were rehybridized with wcps in order to conserve scant patient material.
RT-PCR
RT-PCR and Southern blotting had been carried out on 13 cases as part of a previously published study 6 and RT-PCR only, on a further two cases.
Immunophenotypic studies
Immunophenotypic subgroups of ALL were defined as follows: Null ALL (CD19 
Results
The 159 patients had an age range of 15-88 years (median 27 years). Immunophenotypic studies showed that 67 patients had common ALL, 34 had pre-B ALL, four had common/pre-B ALL, 25 had T ALL, nine were classified as 'other', and one had null ALL. The immunophenotypes of 19 patients were unknown.
Cytogenetic analysis had been successfully performed on 127 patients (80%), of whom 88 had an abnormal karyotype. It had failed in 32 cases. As expected, the cryptic t(12;21)(p13;q22) translocation was not identified in any of them. 
t(12;21)-positive cases
The clinical, cytogenetic and interphase FISH findings for the positive cases are presented in Table 1 . In seven cases (1-7), 50-100% of nuclei showed co-localization of ETV6 and AML1 indicating the presence of the t(12;21) translocation. The positive interphase FISH results were confirmed on metaphases by the observation of the ETV6/AML1 fusion signal on the derived chromosome 21 in all cases. Further proof was provided with wcps 12 and 21, showing exchange of material between these two chromosomes (cases 2, 4 and 5) and by RT-PCR (case 7).
The patients ranged in age from 15 to 50 years and all of them showed a common ALL immunophenotype. The presentation white cell counts were below 10 × 10 9 /1. except in the one patient who had a white cell count of over 200 × 10 9 /1. Cytogenetic analysis had failed in three cases (1, 3 and 6) and was incomplete in a fourth (case 7). In the other three cases (2, 4 and 5) abnormalities of 12p were detected as part of a complex karyotype.
The median follow-up time was 19 months. Two patients (cases 1 and 4), relapsed at 24 and 11 months and did not achieve a second remission. A third (case 5), relapsed at 10 months, 4 months after an autologous bone marrow transplant, while a fourth, (case 3), developed acute myeloid leukemia within 29 months of presentation.
In a further seven patients, 4.8-7.2% of nuclei showed colocalization of ETV6 and AML1 suggesting the presence of the t(12;21)(p13;q22) translocation in a low proportion of cells. In none of the seven cases, however, was the fusion signal observed in metaphase cells, while RT-PCR was negative for the one case tested. In view of this lack of confirmation and the low level of fusion signals, these results were presumed to be false positives, with an incidence of 4.6% (7/152 cases).
t(12;21)-negative cases
Of the 152 cases that were negative for the ETV6/AML1 fusion, 121 showed the expected two signals for each of the ETV6 and AML1 genes. The results for the other 31 cases are shown in Table 2 . In 15 cases the results were compatible with the karyotype. Thus, in seven cases (8) (9) (10) (11) (12) (13) (14) with visible deletions of 12p, there was loss of one ETV6 signal, while in six cases (13) (14) (15) (16) (17) (18) with extra copies of chromosome 21, there were concordant gains of AML1.
Only one of the cytogenetic populations seen in case 19 appeared to be represented at interphase, while in three cases (20) (21) (22) with very incomplete karyotypes, the extra signals observed were not unexpected given the numbers of chromosomes involved.
Leukemia
In seven cases with failed or normal cytogenetics (23) (24) (25) (26) (27) (28) (29) , the numbers of centromeric signals for chromosomes 12 and 13/21 successfully defined by Multiprobe-I, agreed with those for ETV6 and AML1. Although cytogenetics had failed for case 30, wcps on unanalyzable metaphases showed two derived chromosomes containing 13 material which could have resulted in the loss of one 13 centromere and thus explain the five signals observed by Multiprobe-I for 13/21 centromeres.
In case 31 the unexpected finding of a small population of cells with four signals each for ETV6 and AML1 was confirmed as a small tetraploid clone by the use of Multiprobe-I.
Four cases showed unexpected loss of ETV6. These deletions were cytogenetically invisible in two cases (32 and 33), while cytogenetics was inadequate and therefore uninformative for the other two (34 and 35) .
There were unexpected extra AML1 signals in interphase nuclei in three cases (36) (37) (38) . In case 36, several signals for AML1 were located on what appeared to be an apparently normal chromosome 21 using wcp 21. Although the chromosome number by Multiprobe-I was in the hyperdiploid range in this patient, the gains were untypical of classical hyperdiploidy with only four copies of 13/21 centromeres. In case 37 the extra signals appeared to be on a number of small chromosomes, which probably represented the markers of the poor quality cytogenetic preparation. In case 38 the four signals were tandemly repeated along the length of an abnormal marker, which subsequently proved to be composed entirely of chromosome 21 material.
Discussion
This study is the first report of the use of interphase FISH for the identification of ETV6/AML1 fusion in a series of adult patients. It also represents the largest series of adult patients in which the incidence of the translocation has been studied. The technique has been used for series of childhood ALLs, in which the results differ strikingly from this one in the much higher incidence of positive cases. [24] [25] [26] In previously reported series of adults, 6, [11] [12] [13] [14] the molecular technique of RT-PCR was used.
Seven positive cases were found among 159 adult patients in the present study, an incidence of 4.4%. This figure is a little higher than those reported for the other adult series (0-3.3%), which may be due to chance and simply reflect the larger size of our sample, or result from a real geographical variation in incidence. 14 The most likely explanation, however, is that FISH may identify cases with alternative breakpoints in the gene which are missed by RT-PCR. 27 In our series RT-PCR was only performed on 15 cases but one of these proved to be positive by FISH and negative by RT-PCR. Previously described ETV6/AML1 fusion-positive adults were aged between 15 and 27 years, except for one 45-year-old man, 10 whose positivity was subsequently not confirmed.
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Our two positive patients, aged 43 and 50 years old, respectively, are thus among the oldest reported. Similar to findings in childhood cases, ETV6/AML1 fusion was associated with a low white blood count, a common ALL immunophenotype, cytogenetically identifiable 12p abnormalities and in two cases a near triploid/tetraploid clonal karyotype. 5, 20, 28 The deletion of the second ETV6 allele which has been reported to occur frequently in children with the fusion gene, was only observed in two of the positive adults. Although the occurrence of intragenic deletions or point mutations undetectable by FISH techniques cannot be ruled out, outcome could be in some way related to the retention of this second allele. Due to the infrequency of the t(12;21) translocation in adults, its influence on prognosis has yet to be resolved. In this series, three of the ETV6/AML1 fusion-positive patients relapsed. In one, with a complex karyotype, the second copy of the ETV6 allele was retained in the abnormal cells at both diagnosis and relapse. In the other two, both with unsuccessful cytogenetics, ETV6 was retained in the abnormal cells of one but deleted from those of the other. A fourth patient developed secondary acute myeloblastic leukemia within 29 months of presentation. Firm conclusions on the influence of this translocation on outcome await a longer follow-up and larger numbers of patients. However, it appears unlikely that the t(12;21) translocation is associated with a uniformly improved outcome in adults.
The AML1 probe used spans the breakpoint on chromosome 21 and is designed to give an extra signal on the derived chromosome 12 in positive cases. In this study, the additional signal was only clearly visible in three of the positive cases and then in only some of the positive nuclei. Care must therefore be taken in relying on the extra signal for confirmation of positivity. A possible explanation is that there has been a partial deletion of the AML1 gene involved in the AML1/ETV6 fusion. This is supported by recent findings in our laboratory, where we observed that in some positive childhood cases, the 21 material translocated to the short arm of chromosome 12 did not always include AML1 exons (unpublished observations). This interpretation is supported by similar results obtained with probes to the MLL gene. 29 The sensitivity of dual-color interphase FISH is limited by the occurrence of false positive results. Studies using similar probes for BCR/ABL fusion showed that hyperdiploidy 22 or the small-condensed nuclei characteristic of T ALL, 30 may produce higher rates of false positivity. In our series only one each of the 16 cases with hyperdiploidy and the 25 cases with T ALL had slightly raised fusion rates. However, in all the false positive cases, the proportion of fusion signal positive nuclei was far lower than in the confirmed t(12;21) cases.
In 31 cases, which were negative for ETV6/AML1 fusion, the expected two signals for each of the genes were not seen at interphase. There was, however, a close agreement for the majority of these cases between the interphase FISH results and those obtained by cytogenetics or by Multiprobe-I. The case in which only one cytogenetic population appeared to be represented at interphase may have been due to the poor quality of the preparation, or it could reflect a real chromosomal difference between cells in division and in interphase, which we have observed in our laboratory in some cases of hyperdiploidy (unpublished observations), and has also been reported elsewhere. 31 In four cases the results obtained with the ETV6 probe were the only indication that there had been a deletion of the gene. This reflects the common association between ALL and abnormalities of 12p. 32 We have also observed this phenomenon in a series of childhood ALLs, where 3/30 cases which were negative for ETV6/AML1 fusion, showed deletions of ETV6 which were not suspected from the cytogenetics (unpublished observations).
Abnormal numbers of chromosome 21 are also a recurrent feature of ALL. 33 The finding of additional copies of AML1 was the first clue to the presence of hidden hyperdiploidy, confirmed by Multiprobe-I in seven patients. In three other cases discordant results between cytogenetics and interphase FISH led to the discovery of AML1 amplification, which has been described in both childhood and adult ALL. [34] [35] [36] In one of our cases, the extra signals were found on a quadruplicated chromosome 21, a finding previously reported in a child. 37 In the light of our results, we conclude that dual-color ETV6/AML1 interphase FISH is a simple, efficient and relatively quick method of screening for the t(12;21) translocation among adult patients with ALL. The translocation appears to occur over a larger age range than previously suspected and may have a more heterogeneous prognosis in adults than in children. An added advantage to using these probes is in the extra genetic information they provide about patients who do not have the fusion gene.
Leukemia
The reliability of the method is underlined by the remarkable agreement between its results and those obtained by other techniques. Although occasional 'false positives' did occur, they were easily distinguishable from true positivity by the small percentages of cells involved. Thus confidence can be placed in the exclusive use of interphase FISH for determining ETV6/AML1 fusion.
